WallStreetZenWallStreetZen

NASDAQ: AYTU
Aytu Biopharma Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Aytu Biopharma earnings were $1.6M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest AYTU earnings report on Mar 31, 2025 announced Q1 2025 earnings of $4.0M, up 406.9% from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, AYTU reported annual earnings of -$15.8M, with -7.1% growth.

AYTU earnings history

Current Revenue
$69.2M
Current Earnings
$1.6M
Current Profit Margin
2.4%

AYTU Return on Equity

Current Company
5.3%
Current Industry
12.8%
Current Market
31.3%
AYTU's Return on Equity (5.3%)... subscribe to Premium to read more.
High Return on Equity Performance

AYTU undefined

Current Company
1.4%
Current Industry
6.9%
AYTU is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when AYTU announces earnings.

AYTU undefined

Current Company
18.88%
Current Industry
14.3%
AYTU has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AYTU vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AYTU$16.13M$1.64MN/A$0.20
GELSN/AN/AN/AN/A
FLGC-$12.47M-$13.32MN/A-$0.98
TXMD-$1.69M-$2.10MN/A-$0.18
IXHL-$21.16M-$21.74MN/A-$1.21
View Top Pharmaceutical Stocks

Aytu Biopharma Earnings Reports & History FAQ

What were Aytu Biopharma's earnings last quarter?

On AYTU's earnings call on Invalid Date, Aytu Biopharma (NASDAQ: AYTU) reported Q1 2025 earnings per share (EPS) of $0.65, up 225% year over year. Total AYTU earnings for the quarter were $3.99 million. In the same quarter last year, Aytu Biopharma's earnings per share (EPS) was -$0.52.

If you're new to stock investing, here's how to buy Aytu Biopharma stock.

Is Aytu Biopharma profitable or losing money?

As of the last Aytu Biopharma earnings report, Aytu Biopharma is currently profitable. Aytu Biopharma's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $1.64 million, a 111.98% decrease year over year.

What was AYTU's earnings growth in the past year?

As of Aytu Biopharma's earnings date in Invalid Date, Aytu Biopharma's earnings has grown year over year. AYTU earnings in the past year totalled $1.64 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.